12 Oversold Blue Chip Stocks to Buy According to Analysts
Oversold blue chip stocks are drawing a closer look, but not just because they have fallen.
Insulet Corp (PODD)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Zevenbergen Capital Investments Nancy Zevenbergen | 139,407 | $29,253,165 | +24% | 0.84% |
| 2. | Ayrshire Capital Management John Nevin Jr. | 4,932 | $1,035,024 | -3% | 0.54% |
| 3. | Bayforest Capital Theodoros Tsagaris | 308 | $64,631 | -61% | 0.07% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $246.23 | 2,030 | $499,846.90 | 17,483 | 2026-02-25 | Filing | |
| $239.35 | 4,300 | $1,029,205.00 | 13,916 | 2026-02-20 | Filing | |
| $311.73 | 962 | $299,884.26 | 4,591 | 2025-12-05 | Filing | |
| $206.00 | 100 | $20,600.00 | 13,314 | 2024-08-29 | Filing | |
| $168.92 | 1 | $168.92 | 4,032 | 2023-09-19 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $293.09 | 1,851 | $542,509.59 | 2,158 | 2025-12-15 | Filing | |
| $347.49 | 687 | $238,725.63 | 3,456 | 2025-09-08 | Filing | |
| $348.81 | 797 | $278,001.57 | 3,890 | 2025-09-08 | Filing | |
| $332.23 | 4,263 | $1,416,296.49 | 16,736 | 2025-08-21 | Filing | |
| $320.00 | 1,343 | $429,760.00 | 4,143 | 2025-08-07 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 105,228 | $22,081,044 | 0.16% | |
| 2. | 72,658 | $15,246,555 | 0.24% | |
| 3. | 68,396 | $14,352,217 | 0.59% | |
| 4. | 19,159 | $4,020,325 | 0.03% | |
| 5. | 18,000 | $3,201,336 | 0.01% |
News See All
7 Oversold Stocks to Buy with Double-Digit ROE Growth
In this article, we will look at oversold names that offer double-digit ROE growth for investors across sectors.
15 Stocks Set to Explode in the Next 3 Years
Ongoing market volatility tied to the Iran conflict is changing investor behavior, with a growing preference for more selective positioning.
8 Most Oversold Strong Buy-Rated Stocks to Invest In
Oversold stocks are getting a fresh look in 2026, but not simply because they are down.
Truist Maintains Insulet Corporation (PODD) Buy Rating Despite Device Correction Announcement
TheFly reported on March 13 that Truist observed that PODD shares declined after the company disclosed a Voluntary Device Correction for certain Omnipod 5 lots.
10 Quality Value Stocks Likely to Make a Comeback According to Analysts
Fidelity portfolio managers believe that predicting which stocks will lead in the coming year remains difficult, especially as market uncertainty continues to dominate investor sentiment.
Truist Lowers its Price Target on Insulet Corporation (PODD) to $360 and Maintains a Buy Rating
Truist on February 19, 2026, lowered its price target on Insulet Corporation (NASDAQ:PODD) to $360 from $390 and maintained a Buy rating.
O5 Adoption Leads to Bullish Views Around Insulet Corporation (PODD)
On February 4, Stifel lowered its price target on Insulet Corporation (NASDAQ:PODD) from $370 to $350. The firm reiterated a Buy rating on the shares, with a revised upside of almost 45%.
10 Best Healthcare Equipment Stocks to Buy According to Hedge Funds
The Healthcare Equipment segment is one of the areas across the broader healthcare landscape that carries immense innovation prospects and also offers a defensive play.
Insulet Corporation (NASDAQ:PODD) Q4 2025 Earnings Call Transcript
Operator: Good morning, and welcome to the Insulet Corporation Fourth Quarter and Full Year 2025 Earnings Call. As a reminder, this conference call is being recorded.